Spinib contains Dasatinib, an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It works by inhibiting abnormal tyrosine kinase activity associated with certain leukemia cells, thereby helping suppress their growth and proliferation.

Dasatinib is primarily used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) in specific clinical settings.

What is Dasatinib?

Dasatinib is a tyrosine kinase inhibitor that blocks several kinases, including BCR-ABL, SRC-family kinases, and other signaling proteins involved in cancer-cell proliferation.

By inhibiting BCR-ABL signaling, Dasatinib helps suppress the abnormal growth of leukemia cells carrying the Philadelphia chromosome.

Spinib (Dasatinib) is a prescription oncology medicine and should be used under the supervision of a qualified hematologist or oncologist.

Benefits and Uses of Dasatinib

Dasatinib may be used for:

• Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in appropriate patients
• Treatment of selected CML patients who have developed resistance or intolerance to previous therapy
• Targeted inhibition of BCR-ABL tyrosine kinase
• Suppression of abnormal leukemia-cell proliferation

The appropriate indication and treatment regimen depend on the patient’s disease characteristics, treatment history, and clinical condition.

Dosage Guidelines

The dosage of Dasatinib varies according to the disease phase, indication, age, treatment response, and other clinical factors.

• Take Spinib exactly as prescribed by the treating oncologist or hematologist.
• Dasatinib is generally administered orally once daily for many indications, although dosing schedules can vary.
• Tablets should be swallowed whole with water.
• Dasatinib may generally be taken with or without food.
• Do not crush or break tablets unless specifically instructed by a healthcare professional.
• Do not change the dose or discontinue treatment without medical advice.
• Regular blood counts and other clinical monitoring may be required during therapy.

Wholesale & Supply

Onco India International supports the wholesale and international supply of Dasatinib products for eligible pharmaceutical distributors, importers, hospitals, and healthcare suppliers.

Bulk procurement can be discussed according to:

• Required quantity
• Destination country
• Packaging requirements
• Regulatory requirements
• Shipping and documentation requirements

Buying Dasatinib Online

Dasatinib is a prescription targeted anticancer medicine and should be sourced through authorized pharmaceutical suppliers and distributors.

For commercial or institutional requirements of Spinib (Dasatinib), customers can contact Onco India International for product information, documentation, and supply requirements.

Reviews

Individual responses to Dasatinib can vary depending on the leukemia subtype, disease phase, previous treatments, dosage, and patient characteristics. Treatment response should be assessed through appropriate hematological and molecular monitoring by the treating specialist.

Quality Assurance

Dasatinib products should be manufactured, tested, packaged, and stored according to applicable pharmaceutical quality standards and regulatory requirements.

Relevant product documentation and quality information can be provided according to customer requirements and destination-market regulations.

Frequently Asked Questions

What is Spinib used for?

Spinib contains Dasatinib and is used for the treatment of certain Philadelphia chromosome-positive leukemias, including CML and Ph+ ALL.

What type of medicine is Dasatinib?

Dasatinib is a tyrosine kinase inhibitor (TKI) and targeted anticancer medicine.

How does Dasatinib work?

Dasatinib inhibits BCR-ABL and several other tyrosine kinases involved in abnormal leukemia-cell signaling and proliferation.

What cancers can Dasatinib treat?

Dasatinib is primarily used for specific forms of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

How should Dasatinib be taken?

Dasatinib is generally taken orally according to the prescribed treatment regimen and may usually be taken with or without food.

What are the common side effects of Dasatinib?

Possible adverse effects include low blood-cell counts, diarrhea, nausea, headache, fatigue, skin rash, and fluid retention. More serious complications, including pleural effusion and pulmonary hypertension, can occur and require medical attention.

Does Dasatinib require regular monitoring?

Yes. Blood counts and other clinical parameters may need to be monitored regularly during treatment. Additional monitoring may be required depending on the patient’s condition and risk factors.

Does Dasatinib require medical supervision?

Yes. Dasatinib is a prescription oncology medicine and should be used under the supervision of a hematologist or oncologist.

Conclusion

Spinib (Dasatinib) is a targeted tyrosine kinase inhibitor used primarily in the treatment of Philadelphia chromosome-positive CML and Ph+ ALL. By inhibiting BCR-ABL and other relevant kinases, Dasatinib helps suppress abnormal leukemia-cell growth. Treatment should be individualized and monitored by an experienced healthcare professional.